Falk Gastro Info 4/2015

Video

 

 

Video course abdominal ultrasound

 

Differentiation of small and large intestine

 

Author: Prof. Dr. Christoph F. Dietrich, Caritas Krankenhaus Bad Mergentheim.

©2015 Falk Foundation e.V., Freiburg. All rights reserved.

 

 

Please switch on your loudspeakers!

 

 

Link to Falk Mediacenter:

http://media.falkfoundation.de/index.php?id=154&L=1

 

 

Link to the video directly:

http://media.drfalkpharma.de/fileadmin/media/44_Gastro_Differentiation_of_small_and_large_intestine_ENG.mp4

 

 

Preview images:

 

180 x 112 pixels

http://www.drfalkpharma.de/fileadmin/media/newsletter/Logos/Sono_Clip44_180P.jpg

 

580 x 350 pixels

http://www.drfalkpharma.de/fileadmin/media/newsletter/Logos/Sono_Clip44_580.jpg

 

 

 

 

Bowel

 

 

 

Text:

Bröms G et al, Inflamm Bowel Dis. 2014;20(6):1091–8

Women suffering from ulcerative colitis and Crohn’s disease are at increased risk of adverse birth outcomes, such as stillbirth, growth restriction, and preterm birth.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20368#28361

 

 

 

 

Text:

Karner M et al, Am J Gastroenterol. 2014;109(7):1041–51

Modified release LT-02 (phosphatidylcholine) treatment in ulcerative colitis refractory to mesalazine leads to a statistically significant improvement in disease activity compared to placebo.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20368#c28362

 

 

 

 

Text:

Kelly CR et al, Am J Gastroenterol. 2014;109(7):1065–71

Fecal microbiota transplantation is effective and relatively safe in the treatment of Clostridium difficile infection in immunocompromised patients.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20368#c28363

 

 

 


 

Liver
Biliary Tracts

 

 

 

Text:

Kawaguchi T et al, Clin Gastroenterol Hepatol. 2014;12(6):1012–8

Branched-chain amino acid supplementation reduces the risk for HCC and prolongs survival of patients suffering from liver cirrhosis.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20368#c28364

 

 

 

 

Text:

Trivedi PJ et al, Clin Gastroenterol Hepatol. 2014;12(7):1179–85

The majority of women with PBC maintain stable liver biochemistry during pregnancy, although postpartum biochemical exacerbations are common.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20368#c28365

 

 

 

 

 

Text:

Rodríguez E et al, J Hepatol. 2014;60(5):955–61

Early treatment with terlipressin and albumin in patients with type-1 hepatorenal syndrome associated with sepsis is effective and safe.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20368#c28366

 

 

 

 

 

 

 

 

 

 

 

 

 

Oesophagus

Stomach

Duodenum

 

 

 

Text:

Song P et al, J Cancer Res Clin Oncol. 2014;140(6):979–92

Increased intake of red meat might be a risk factor for stomach cancer.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20368#c28367

 

 

Text:

Selgrad M et al, Int J Cancer. 2014;135(5):1127–31

Helicobacter pylori infection is associated with an increased risk for the development of colonic neoplasm.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20368#c28368

 

 

Text:

Anders M et al, Gut. 2014;63(10):1535–43

Even after seemingly complete endoscopic resection, recurrence of Barrett’s esophagus is frequent and independent of additional thermal therapy.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20368#c28369

 

 

Pancreas

 

 

Text:

Taguchi M et al, Pancreas. 2014;43(6):863–6

Underweight and overweight are independent risk factors for mortality in acute pancreatitis.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20368#c28370

 

 

 

 


 

Current Falk literature:

 

 

Aftercare Following Liver Transplantation

Recommended Practices for Cooperation Between the Primary Care Provider and the Transplant Center

Authors: K. Herzer, G. Gerken

(35 pages)

U13e

 

 

Picture:

http://www.drfalkpharma.de/fileadmin/media/Falk_Broschueren/Diagnostik_und_Therapie/Titelblatt/U13e_1-8-13.png

 

PDF:

http://www.drfalkpharma.de/fileadmin/media/Falk_Broschueren/Diagnostik_und_Therapie/PDF/U13e_1-8-13.pdf

 

 

 

 

Order by email (Please replace text by your email address):

 

mailto:text?subject=FGI%24%2F2015:%20Ordering%20of%20brochure%20U13e&body=Please%20send%20the%20brochure%20to%20the%20following%20address:%0A%0A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Zašto granule imaju povoljniji klinički učinak?

 

  • Značajno veća površina sluznice je “pokrivena” aktivnom supstancom (slika!)

 

= 3 grama granula “pokrije” 16.000 mm2 sluznice!